Pub Date : 2026-01-01Epub Date: 2025-06-20DOI: 10.1016/j.remnie.2025.500180
M.T. Tatoğlu , H. Uslu
Subcutaneous emphysema may occur iatrogenically, spontaneously, or post-traumatically as a result of free air passage under the skin from the respiratory tract or gastrointestinal tract. In this case, we present the typical appearance of a case of massive subcutaneous emphysema observed on [18F]-FDG PET/CT for metabolic characterization due to a massive lesion in the lung and the images of complete resorption after seven months.
{"title":"Massive subcutaneous emphysema and complete resorption images detected on [18F]-FDG PET/CT","authors":"M.T. Tatoğlu , H. Uslu","doi":"10.1016/j.remnie.2025.500180","DOIUrl":"10.1016/j.remnie.2025.500180","url":null,"abstract":"<div><div>Subcutaneous emphysema<span> may occur iatrogenically, spontaneously, or post-traumatically as a result of free air passage under the skin from the respiratory tract or gastrointestinal tract. In this case, we present the typical appearance of a case of massive subcutaneous emphysema observed on [18F]-FDG PET/CT for metabolic characterization due to a massive lesion in the lung and the images of complete resorption after seven months.</span></div></div>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"45 1","pages":"Article 500180"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-04DOI: 10.1016/j.remnie.2025.500203
F. Sebastián Palacid, B. Pérez López, N. Álvarez Mena, C. Riola Parada, C. Gamazo Laherrán, R. Ruano Pérez
{"title":"Metabolic alterations on brain [18F]FDG PET in a case of postcoital transient global amnesia","authors":"F. Sebastián Palacid, B. Pérez López, N. Álvarez Mena, C. Riola Parada, C. Gamazo Laherrán, R. Ruano Pérez","doi":"10.1016/j.remnie.2025.500203","DOIUrl":"10.1016/j.remnie.2025.500203","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"45 1","pages":"Article 500203"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145008609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-05DOI: 10.1016/j.remnie.2025.500218
E. Abou Jokh Casas , J.L. Vercher Conejero , A. Repetto , P. Bello Arques , T. Cambil Molina , A. Rodriguez Gasén , J.A. Vallejo Casas
The use of theragnostics in nuclear medicine has significantly advanced, particularly peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors. Meningiomas often overexpress somatostatin receptors (SSTR), making them potential candidates for PRRT. However, the lack of large-scale standardized trials limits its clinical application.
Meningiomas are the most common primary intracranial tumors; the treatment of choice for which is surgical resection or, if that's not possible, radiotherapy. However, some cases are refractory to standard treatments, leading to the exploration of other therapeutic options, such as targeted therapy with radioligands. Studies have demonstrated promising results with [177Lu]Lu-DOTATATE in meningiomas expressing SSTR2, improving progression-free survival (PFS) in refractory cases.
Current evidence suggests that PRRT is a viable option for refractory meningiomas with high SSTR expression. However, further clinical trials are needed to establish standardized protocols, optimize patient selection criteria, and explore combination therapy strategies to improve outcomes. This review highlights the mechanisms, clinical applications, and future perspectives of [177Lu]Lu-DOTATATE in meningiomas, providing insights into its expanding role in this pathology.
{"title":"Treatment with radionuclide-labeled peptides in refractory meningiomas: Updated review and clinical perspectives","authors":"E. Abou Jokh Casas , J.L. Vercher Conejero , A. Repetto , P. Bello Arques , T. Cambil Molina , A. Rodriguez Gasén , J.A. Vallejo Casas","doi":"10.1016/j.remnie.2025.500218","DOIUrl":"10.1016/j.remnie.2025.500218","url":null,"abstract":"<div><div>The use of theragnostics in nuclear medicine has significantly advanced, particularly peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors. Meningiomas often overexpress somatostatin receptors (SSTR), making them potential candidates for PRRT. However, the lack of large-scale standardized trials limits its clinical application.</div><div>Meningiomas are the most common primary intracranial tumors; the treatment of choice for which is surgical resection or, if that's not possible, radiotherapy. However, some cases are refractory to standard treatments, leading to the exploration of other therapeutic options, such as targeted therapy with radioligands. Studies have demonstrated promising results with [<sup>177</sup>Lu]Lu-DOTATATE in meningiomas expressing SSTR2, improving progression-free survival (PFS) in refractory cases.</div><div>Current evidence suggests that PRRT is a viable option for refractory meningiomas with high SSTR expression. However, further clinical trials are needed to establish standardized protocols, optimize patient selection criteria, and explore combination therapy strategies to improve outcomes. This review highlights the mechanisms, clinical applications, and future perspectives of [<sup>177</sup>Lu]Lu-DOTATATE in meningiomas, providing insights into its expanding role in this pathology.</div></div>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"45 1","pages":"Article 500218"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145016932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-06-20DOI: 10.1016/j.remnie.2025.500184
A. Aghaee , Z. Bakhshi , V. Roshanravan , N. Norouzbeigi , H. Dadgar , E. Askari , K. Aryana , S. Shafiei , S. Soltani , S. Sadeghpour
Objectives
This study aims to evaluate the diagnostic value of early static and delayed imaging in conjunction with standard 68Ga-PSMA-11 PET/CT scans to detect prostate malignant lesions in prostate cancer patients.
Methods
One hundred and thirty-eight prostate cancer patients underwent routine [68 Ga]Ga-PSMA-11 PET/CT imaging, 4-minute static acquisition post-injection, and delayed imaging 3 h post-injection. The imaging results were analysed for lesion count, type, localisation, and maximum standardised uptake values.
Results
57.97% exhibited positive findings for pathologic prostatic lesions in the standard PET scans (SUVmax: 10.24). In contrast, early PET imaging detected lesions in 58.01% of patients (SUVmax of 5.86), while delayed scans revealed lesions suggestive of malignancy in 55.45% of patients (SUVmax of 12.79). The analysis demonstrated a statistically significant difference in SUVmax values across the time points (P < .001). Pathologic lymph nodes on images 60 min p.i. were revealed by an SUV max 60 min p.i.: 15.78; this number for the first 4 min and after 3 h were 7.36, 19.19, respectively. Metastatic bone lesions on WB were found in 38 patients, more than the ESI (n = 37) and DI (n = 24). In comparison, urinary bladder activity assessment was detectable with the WB imaging SUVmax 60 min 11.07. Even though the SUV max for ESI and DI were 6.95 and 31.97, respectively. In the statistical analysis, pathologic radiotracer uptake in tumour lesions was statistically higher in ESI and WB than in urinary bladder activity.
Conclusions
The findings indicate that neither early [68 Ga]Ga-PSMA-11 PET/CT nor delayed imaging significantly enhanced the overall detection rate of malignant lesions in prostate cancer patients. However, the early 4-minute post-injection acquisition of PET images proved beneficial for distinguishing local bladder invasion more effectively.
目的：本研究旨在评价早期静态和延迟成像结合标准68Ga-PSMA-11 PET/CT扫描对前列腺癌患者前列腺恶性病变的诊断价值。方法：138例前列腺癌患者行常规[68 Ga]Ga- psma -11 PET/CT成像，注射后4分钟静态采集，注射后3小时延迟成像。影像学结果分析病变计数、类型、定位和最大标准化摄取值。结果：57.97%的患者在标准PET扫描中表现为前列腺病理性病变阳性（SUVmax: 10.24）。相比之下，58.01%的患者（SUVmax为5.86）在早期PET成像中发现病变，而55.45%的患者（SUVmax为12.79）在延迟扫描中发现提示恶性病变。分析表明，SUVmax值在不同时间点有统计学意义差异（p max 60 min 11.07）。尽管ESI和DI的SUV max分别为6.95和31.97。在统计分析中，病理放射性示踪剂在肿瘤病变中的摄取在ESI和WB中高于膀胱活动。结论：研究结果表明，早期[68 Ga]Ga- psma -11 PET/CT和延迟显像均未显著提高前列腺癌患者恶性病变的整体检出率。然而，注射后早期4分钟的PET图像采集有助于更有效地识别局部膀胱侵犯。
{"title":"Beyond the standard: Enhancing prostate bed and regional lymph node detection in prostate cancer patients with early and delayed imaging in [68 Ga]Ga-PSMA-11 PET/CT","authors":"A. Aghaee , Z. Bakhshi , V. Roshanravan , N. Norouzbeigi , H. Dadgar , E. Askari , K. Aryana , S. Shafiei , S. Soltani , S. Sadeghpour","doi":"10.1016/j.remnie.2025.500184","DOIUrl":"10.1016/j.remnie.2025.500184","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aims to evaluate the diagnostic value of early static and delayed imaging in conjunction with standard 68Ga-PSMA-11 PET/CT scans to detect prostate malignant lesions in prostate cancer patients.</div></div><div><h3>Methods</h3><div>One hundred and thirty-eight prostate cancer patients underwent routine [68 Ga]Ga-PSMA-11 PET/CT imaging, 4-minute static acquisition post-injection, and delayed imaging 3 h post-injection. The imaging results were analysed for lesion count, type, localisation, and maximum standardised uptake values.</div></div><div><h3>Results</h3><div><span>57.97% exhibited positive findings for pathologic prostatic lesions in the standard PET scans (SUV</span><sub>max</sub>: 10.24). In contrast, early PET imaging detected lesions in 58.01% of patients (SUV<sub>max</sub><span> of 5.86), while delayed scans revealed lesions suggestive of malignancy in 55.45% of patients (SUV</span><sub>max</sub> of 12.79). The analysis demonstrated a statistically significant difference in SUV<sub>max</sub> values across the time points (<em>P</em><span><span> < .001). Pathologic lymph nodes on images 60 min p.i. were revealed by an SUV max 60 min p.i.: 15.78; this number for the first 4 min and after 3 h were 7.36, 19.19, respectively. Metastatic bone lesions<span> on WB were found in 38 patients, more than the ESI (n = 37) and DI (n = 24). In comparison, urinary bladder activity assessment was detectable with the </span></span>WB imaging SUV</span><sub>max</sub><span> 60 min 11.07. Even though the SUV max for ESI and DI were 6.95 and 31.97, respectively. In the statistical analysis, pathologic radiotracer uptake in tumour lesions was statistically higher in ESI and WB than in urinary bladder activity.</span></div></div><div><h3>Conclusions</h3><div>The findings indicate that neither early [68 Ga]Ga-PSMA-11 PET/CT nor delayed imaging significantly enhanced the overall detection rate of malignant lesions in prostate cancer patients. However, the early 4-minute post-injection acquisition of PET images proved beneficial for distinguishing local bladder invasion more effectively.</div></div>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"45 1","pages":"Article 500184"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-06-20DOI: 10.1016/j.remnie.2025.500196
C. Nong, Y. Xing, L. Jiang, Z. Zhao
{"title":"Incidental detection of bone metastases from gastric cancer on [99mTc]Tc-DTPA renal dynamic scintigraphy","authors":"C. Nong, Y. Xing, L. Jiang, Z. Zhao","doi":"10.1016/j.remnie.2025.500196","DOIUrl":"10.1016/j.remnie.2025.500196","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"45 1","pages":"Article 500196"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-06-20DOI: 10.1016/j.remnie.2025.500182
A. Cinar , U.M. Turan , K. Okuyucu , N. Aydinbelge Dizdar , A. Erol , B. Bedi Alpay , P. Akkus Gunduz , M. Ozkara , D. Cayir , E. Alagoz , S. Ince
Introduction and objectives
Locoregional recurrence occurs in up to 28% of patients with papillary thyroid cancer (PTC). Several risk factors contribute to this metastatic process. The latest of them is perinodal infiltration (PNI). PNI refers to the pathological extension of tumor cells through the lymph node (LN) capsule into the perinodal fibroadipose tissue. It has been accepted as a poor predictive variable. This study aimed to evaluate the prognostic significance of PNI in recurrence of PTC and identify predictive parameters associated with the recurrence in PNI (+) patients.
Material and methods
The study included 680 PTC patients with initial LN metastasis (ILNM). Study population was selected from them according to presence or absence of PNI. Eventually, 102 PNI (+) and 122 PNI (−) patients remained eligible for the study. Patients were statistically compared according to demographic, clinicopathologic features both between PNI (+) and PNI (−) groups and within the PNI (+) group over recurrence status.
Results
The recurrence rates were 40% and 15% in PNI (+) and PNI (−) patients, respectively (p < 0.001). The independent predictive factors associated with recurrence were central ILNM (p = 0.005), combined central and lateral ILNM (p = 0.003), ILNM > 5 (p = 0.023), stage III–IV (p = 0.025 and p < 0.001), tumor size (TS) (p < 0.001), ILNM size (p < 0.001), stimulated thyroglobulin (sTg) (p = 0.039). PNI (p = 0.05), central ILNM (p = 0.035) and TS (p = 0.027) remained prognostic variables after multivariate analysis.
Conclusion
PNI positivity is a poor prognostic factor for PTC recurrence. PNI, especially with large TS and central ILNM, should be taken into account when planning RAI therapy in PTC patients.
{"title":"Impact of perinodal infiltration on recurrence in papillary thyroid cancer","authors":"A. Cinar , U.M. Turan , K. Okuyucu , N. Aydinbelge Dizdar , A. Erol , B. Bedi Alpay , P. Akkus Gunduz , M. Ozkara , D. Cayir , E. Alagoz , S. Ince","doi":"10.1016/j.remnie.2025.500182","DOIUrl":"10.1016/j.remnie.2025.500182","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Locoregional recurrence occurs in up to 28% of patients with papillary thyroid cancer (PTC). Several risk factors contribute to this metastatic process. The latest of them is perinodal infiltration (PNI). PNI refers to the pathological extension of tumor cells through the lymph node (LN) capsule into the perinodal fibroadipose tissue. It has been accepted as a poor predictive variable. This study aimed to evaluate the prognostic significance of PNI in recurrence of PTC and identify predictive parameters associated with the recurrence in PNI (+) patients.</div></div><div><h3>Material and methods</h3><div><span>The study included 680 PTC patients with initial LN metastasis (ILNM). Study population was selected from them according to presence or </span>absence of PNI. Eventually, 102 PNI (+) and 122 PNI (−) patients remained eligible for the study. Patients were statistically compared according to demographic, clinicopathologic features both between PNI (+) and PNI (−) groups and within the PNI (+) group over recurrence status.</div></div><div><h3>Results</h3><div><span><span>The recurrence rates were 40% and 15% in PNI (+) and PNI (−) patients, respectively (p < 0.001). The independent predictive factors associated with recurrence were central </span>ILNM<span> (p = 0.005), combined central and lateral ILNM (p = 0.003), ILNM > 5 (p = 0.023), stage III–IV (p = 0.025 and p < 0.001), tumor size (TS) (p < 0.001), ILNM size (p < 0.001), stimulated thyroglobulin (sTg) (p = 0.039). PNI (p = 0.05), central ILNM (p = 0.035) and TS (p = 0.027) remained prognostic variables after </span></span>multivariate analysis.</div></div><div><h3>Conclusion</h3><div><span>PNI positivity is a poor prognostic factor for </span>PTC recurrence. PNI, especially with large TS and central ILNM, should be taken into account when planning RAI therapy in PTC patients.</div></div>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"45 1","pages":"Article 500182"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-09-30DOI: 10.1016/j.remnie.2025.500142
J.R. Infante , A. Utrera , R. Barco , M. Carmona , I. Gallarín , A. Baena , A. Martínez , C. Durán , N. Sicilia , J. Serrano
Aim
Rectocele can cause chronic constipation and altered quality of life. In the presence of severe symptomatology and lack of response to conservative treatment, gastrointestinal motor function should be assessed. The aim of this study was to assess the utility of gastrointestinal transit scintigraphy in this pathology, analyzing its position in international guidelines.
Material and methods
We retrospectively evaluated twelve women with rectocele and chronic constipation, range of 31–74 years, referred for scintigraphic study as an assessment prior to prolapse treatment. Defecography was altered in 12 and anorectal manometry in 8. Following international guidelines, a dose of [111In]In-DTPA (37 MBq) was administered together with standardized food to assess liquid gastric emptying and small-bowel and colonic transit. Areas of interest were defined in these locations to calculate the geometric center.
Results
In 3 patients the radioisotopic study was normal, 3 showed a pattern of outlet obstruction, 3 colonic inertia, 2 slow small-bowel transit and 1 slow generalized transit. Thus, 50% of patients presented transit alterations not located in the rectosigmoid area.
Conclusion
Scintigraphy study provided useful information for the evaluation of patients with rectocele and constipation, influencing the diagnosis and therapeutic management. It proved to be a physiological method, providing both global and regional quantitative information. Like other authors, it is considered appropriate to use the study at the same level as the tests for the assessment of defecatory dynamics.
目的：直肠膨出可引起慢性便秘和生活质量的改变。在存在严重症状且对保守治疗缺乏反应的情况下，应评估胃肠运动功能。本研究的目的是评估胃肠道转运显像在这种病理中的应用，分析其在国际指南中的地位。材料和方法：我们回顾性评估了12名患有直肠前突和慢性便秘的妇女，年龄31-74岁，作为脱垂治疗前的评估。12例大便造影改变，8例肛肠测压改变。根据国际指南，将[111In]In-DTPA剂量（37 m Bq）与标准化食物一起施用，以评估胃液排空和小肠和结肠运输。在这些位置定义感兴趣的区域以计算几何中心。结果：放射性同位素检查正常3例，出口梗阻3例，结肠惯性3例，小肠转运缓慢2例，全身转运缓慢1例。因此，50%的患者表现出不位于直肠乙状结肠区域的中转性改变。结论：闪烁显像研究为直肠前突伴便秘患者的诊断和治疗提供了有用的信息。它被证明是一种生理学方法，提供了全球和区域的定量信息。与其他作者一样，在评估排便动力学的测试水平上使用该研究被认为是适当的。
{"title":"Gastrointestinal transit scintigraphy in the evaluation of rectocele","authors":"J.R. Infante , A. Utrera , R. Barco , M. Carmona , I. Gallarín , A. Baena , A. Martínez , C. Durán , N. Sicilia , J. Serrano","doi":"10.1016/j.remnie.2025.500142","DOIUrl":"10.1016/j.remnie.2025.500142","url":null,"abstract":"<div><h3>Aim</h3><div>Rectocele can cause chronic constipation and altered quality of life. In the presence of severe symptomatology and lack of response to conservative treatment, gastrointestinal motor function should be assessed. The aim of this study was to assess the utility of gastrointestinal transit scintigraphy in this pathology, analyzing its position in international guidelines.</div></div><div><h3>Material and methods</h3><div>We retrospectively evaluated twelve women with rectocele and chronic constipation, range of 31–74 years, referred for scintigraphic study as an assessment prior to prolapse treatment. Defecography was altered in 12 and anorectal manometry in 8. Following international guidelines, a dose of [<sup>111</sup>In]In-DTPA (37 MBq) was administered together with standardized food to assess liquid gastric emptying and small-bowel and colonic transit. Areas of interest were defined in these locations to calculate the geometric center.</div></div><div><h3>Results</h3><div>In 3 patients the radioisotopic study was normal, 3 showed a pattern of outlet obstruction, 3 colonic inertia, 2 slow small-bowel transit and 1 slow generalized transit. Thus, 50% of patients presented transit alterations not located in the rectosigmoid area.</div></div><div><h3>Conclusion</h3><div>Scintigraphy study provided useful information for the evaluation of patients with rectocele and constipation, influencing the diagnosis and therapeutic management. It proved to be a physiological method, providing both global and regional quantitative information. Like other authors, it is considered appropriate to use the study at the same level as the tests for the assessment of defecatory dynamics.</div></div>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"45 1","pages":"Article 500142"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145215013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-06-20DOI: 10.1016/j.remnie.2025.500181
N. Aydinbelge Dizdar , E. Tatci , O. Ozmen
{"title":"A rare case of synchronous bilateral ciliary body adenocarcinoma on [18F]FDG PET/CT and [68Ga]Ga-PSMA PET/CT","authors":"N. Aydinbelge Dizdar , E. Tatci , O. Ozmen","doi":"10.1016/j.remnie.2025.500181","DOIUrl":"10.1016/j.remnie.2025.500181","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"45 1","pages":"Article 500181"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号